Pharmafile Logo

Webinar – Immuno-oncology’s Evolution: Implications for Pharma Market Researchers

November 23, 2016 | immuno-oncology, webinar 

In association with PMGroup

Immuno-oncology therapies that harness the body’s own defences to fight off tumours are widely acknowledged as the new frontier in cancer treatment. Until recently only a few products had reached the market for a limited number of indications.

In this webinar, oncology market research experts Sue Marett, Phil Rosenberg and Claire Fradet Aubignat will explore the key features of the immuno-oncology market and outline the critical success factors that manufacturers need to consider in order to remain competitive.

Find out more: http://www.researchpartnership.com/news/2016/11/webinar-immuno-oncologys-evolution/

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Quantitative specialist joins Research Partnership, London

Global healthcare market research consultancy Research Partnership has appointed Roy Rogers as a Quantitative Director in their UK offices in London

Webcast

Amplifying the patient voice: How to conduct patient research sensitively to uncover emotional insights

Webcast

The power of a good story: Turn your insights into effective storytelling with data visualisation

Article

How will COVID-19 affect uptake of vaccinations against other diseases?

Podcast

Living With Chronic Illness (Series one)

Webcast

China: How pharma can maximize success in this rapidly changing emerging market

Article

Inhale, Exhale: The struggle of living with Severe Asthma and Severe Eosinophilic Asthma

Infographic

Migraine market snapshot

Webcast

Monitoring the impact of COVID-19 on the market access landscape

Live webinar from Singapore

Digital #marcomms: How to evaluate and optimise marketing activities impacted by COVID-19